Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ERADICATE-HF: Ertugliflozin in T2D and Heart Failure
NCT03416270Phase 2Completed
- Sponsor
- University Health Network
- Start
- Jun 2018
- Primary completion
- Apr 2021
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of ertugliflozin in type 2 diabetes mellitus (T2DM), heart failure (HF), sponsored by University Health Network. Started Jun 2018; status: completed.
02
Drugs
ertugliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)heart failure (HF)
Beyond the preview
Go deeper on NCT03416270.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03416270.